Using this criterion for selection, 1800 subjects of mean age 46 years were enrolled between 1982 and 1986, and again between 1988 and the present.
Using this criterion for case definition, the prevalence of COPD seen in family practices was then calculated with its 95% confidence level (95% CI).
Rats in the NP transfer group were classified as rule-based if the number of responses to the first presentation of EF was at least one SD below the mean number of responses to the first presentations of E and F. Using this criterion, none of the rats were classified as rule-based generalizers.
Using this criterion, seven of the thirteen SLE samples had levels of copy number variations in their LDGs that were equivalent to autologous normal-density neutrophils and healthy controls (see Additional file 2).
Using this criterion, none of the variables considered, including a large number of medications (e.g., finasteride, statins) and indications of NSAID use (see Table 1 for a list of these variables), was deemed an empirical confounder, and were therefore excluded from the final models.
Using this criterion 5.6% of the probe values were excluded by being too far above and 2.8% too far below the median.
Using this criterion, 329 of 27,578 CpG sites (1.2%) had missing or invalid β-values in ten or more samples; these sites were dropped from subsequent analysis, leaving 27,249 CpG sites among 367 subjects.
Using this criterion, 11% of otherwise eligible women were classified as underreporters and were excluded from the analysis.
Using this criterion, overexpression of p53 was associated with decreased progression-free survival times on univariate analyses (P<0.04).
Using this criterion, 15 of 74 isolates (20%) were positive for ExoU, ExoT, PcrV, and PopD (Table 4).
